Evidence map›Paper›PMID 36386246›Full record

ArticleDigital health

Smartphone digital phenotyping, surveys, and cognitive assessments for global mental health: Initial data and clinical correlations from an international first episode psychosis study.

Tanvi Lakhtakia, Ameya Bondre, Prabhat Kumar Chand, Nirmal Chaturvedi, Soumya Choudhary, Danielle Currey, Siddharth Dutt, Azaz Khan, Mohit Kumar, Snehil Gupta and 15 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06043778 (Digital Implementation Support to Achieve Uptake and Integration of Task-Shared Care for Schizophrenia in Primary Care in India), which is not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06043778 nanot yet recruitingnot on this map

Digital Implementation Support to Achieve Uptake and Integration of Task-Shared Care for Schizophrenia in Primary Care in India

TypeinterventionalSponsorHarvard Medical School (HMS and HSDM)Ran2026 to 2029Enrolled240ConditionsSchizophrenia, Schizophrenia and Related Disorders, Psychosocial FunctioningArmsCommunity care for People with Schizophrenia in India (COPSI), mindLAMP Mobile Application
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Validation and normative data for the BAC app in Spanish-speaking individuals with psychosis and healthy controls.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 2 countries.

Tanvi LakhtakiaDivision of Digital Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Ameya BondreSangath, Bhopal, India.ORCID https://orcid.org/0000-0003-1359-4613
Prabhat Kumar ChandDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Nirmal ChaturvediSangath, Bhopal, India.
Soumya ChoudharyDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Danielle CurreyDivision of Digital Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Siddharth DuttDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Azaz KhanSangath, Bhopal, India.
Mohit KumarDepartment of Psychiatry, AIIMS Bhopal, All India Institute of Medical Sciences Bhopal, Bhopal, India.
Snehil GuptaDepartment of Psychiatry, AIIMS Bhopal, All India Institute of Medical Sciences Bhopal, Bhopal, India.
Srilakshmi NagendraDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Preethi V ReddyDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Abhijit RozatkarDepartment of Psychiatry, AIIMS Bhopal, All India Institute of Medical Sciences Bhopal, Bhopal, India.
Luke ScheuerDivision of Digital Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Yogendra SenSangath, Bhopal, India.
Ritu ShrivastavaSangath, Bhopal, India.
Rahul SinghSangath, Bhopal, India.
Jagadisha ThirthalliDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Deepak Kumar TugnawatSangath, Bhopal, India.
Anant BhanSangath, Bhopal, India.
John A NaslundDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Vikram PatelDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Matcheri KeshavanDivision of Digital Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Urvakhsh Meherwan MehtaDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
John TorousDivision of Digital Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-5362-7937
Sangath · INNational Institute of Mental Health and Neurosciences · INBeth Israel Deaconess Medical Center · USAll India Institute of Medical Sciences Bhopal · INHarvard University · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

Objective: To examine feasibility and acceptability of smartphone mental health app use for symptom, cognitive, and digital phenotyping monitoring among people with schizophrenia in India and the United States. Methods: Participants in Boston, USA and Bhopal and Bangalore, India used a smartphone app to monitor symptoms, play cognitive games, access relaxation and psychoeducation resources and for one month, with an initial clinical and cognitive assessment and a one-month follow-up clinical assessment. Engagement with the app was compared between study sites, by clinical symptom severity and by cognitive functioning. Digital phenotyping data collection was also compared between three sites. Results: By Kruskal-Wallis rank-sum test, we found no difference between app activities completed or digital phenotyping data collected across the three study sites. App use also did not correlate to clinical or cognitive assessment scores. When using the app for symptom monitoring, preliminary findings suggest app-based assessment correlate with standard cognitive and clinical assessments. Conclusions: Smartphone app for symptom monitoring and digital phenotyping for individuals with schizophrenia appears feasible and acceptable in a global context. Clinical utility of this app for real-time assessments is promising, but further research is necessary to determine the long-term efficacy and generalizability for serious mental illness.

Indexed as

digital healthglobal healthmental healthSchizophreniasmartphone apps

Identifiers

PMID36386246
PMCPMC9647298
OpenAlexW4309364610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.